H.B. Fuller Rejects Ancora's Raised $1.2B–$1.4B Bid, Opens Market Check of Non-Core Units
FUL is trading near its 52-week low of $46.7 (9.9% above the low).
Summary
The board unanimously turned down Ancora's second unsolicited bid for the Building Adhesive Solutions unit, now $1.2 billion to $1.4 billion in cash, saying the modest increase still undervalues the business and the terms remain highly conditional. That follows the August 24 rejection of Ancora's initial approach and the late-September raise to that range. The more consequential new item: H.B. Fuller will run a market check on select segments and product lines it considers less integral, with any proceeds earmarked for debt reduction, and expects to finish by year-end 2026. The company is already levering up for the Advanced Medical Solutions acquisition, having priced $850 million of 7.625% notes due 2034 on October 9 after downsizing from $950 million, so asset sales would ease that load. The board keeps the door open to maximizing value, but the BAS unit itself stays in the portfolio for now. Watch the year-end 2026 market check outcome for what actually gets separated and at what price.
At the time of this announcement, FUL was trading at $51.32 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $46.70 to $68.63. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.